Diseases, Conditions, Syndromes
US announces clinical trial of antibody treatment for COVID-19
The US has begun late stage clinical trials into a drug formulated to fight COVID-19, officials said Tuesday.
Aug 4, 2020
0
42
News tagged with clinical infectious diseases
Medications
In pre-clinical trials, drug shows potential to combat exaggerated inflammation associated with COVID-19
Experiments involving animals and human cells conducted at the University of São Paulo (USP) in Brazil suggest that niclosamide, an anthelmintic widely used against tapeworms, effectively inhibits SARS-CoV-2 replication ...
Oct 21, 2022
0
54
Medications
New COVID-19 treatment trial results published
A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to ...
Jan 15, 2021
0
5
Inflammatory disorders
Targeting necroptosis for inflammatory myopathies
A new study has suggested that treatment to target necroptosis in muscle fibers using a necroptosis inhibitor lessens myositis-induced muscle weakness as well as muscle cell death and inflammation in the muscles. This has ...
Mar 1, 2022
0
55
Diseases, Conditions, Syndromes
The relationship between viral dose and COVID-19 severity
Over the course of the COVID-19 pandemic, scientists have strived to answer basic questions about the amount of SARS-CoV-2 virus required to cause an infection and how that viral dose influences disease severity. Answers ...
Nov 10, 2021
0
9
Medical research
Mimicking cancer's evasive tactics, microparticles show promise for transplant rejection
Inspired by a tactic cancer cells use to evade the immune system, University of Pittsburgh researchers have engineered tiny particles that can trick the body into accepting transplanted tissue as its own.
Mar 13, 2020
0
54
Diseases, Conditions, Syndromes
Trial shows that the antibiotic azithromycin does not prevent mild COVID cases progressing to hospitalization, death
A new study (the ATOMIC2 trial), presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published simultaneously in The Lancet Respiratory Medicine, shows the antimicrobial ...
Jul 10, 2021
0
3
Gerontology & Geriatrics
New study underscores need for COVID-19 booster shots for older adults
In a study of more than 80 men and women from Baltimore, Maryland, Johns Hopkins researchers have added to evidence that COVID-19 booster shots are essential for maintaining long-term immunity against infection, particularly ...
Sep 29, 2022
0
22
HIV & AIDS
Human immune system can control re-awakened HIV, suggesting 'kick and kill' cure is possible
The human immune system can handle large bursts of HIV activity and so it should be possible to cure HIV with a 'kick and kill' strategy, finds new research led by UCL, the University of Oxford and the University of North ...
Apr 13, 2015
0
21
Medications
Not enough new antibiotics in the pipeline, WHO review concludes
A review from WHO on the number of new antibiotics currently in the pipeline shows that just 12 new antibiotics have entered the market in the five years from 2017-21. And there are far too few (just 27) under development ...
Mar 16, 2023
0
9
